glp 1 and prostate cancer Potential preventive properties of GLP-1 receptor agonists against cancer: a nationwide cohort study | Diabetologia Frontiers | Glucagon-like peptide-1 receptor

Your GP can: Assess your current weight, BMI, and metabolic health to determine clinical need Review existing treatment options that are currently licensed and available in the UK, which may include orlistat, naltrexone/bupropion (Mysimba), semaglutide 2.4 mg (Wegovy approved by the MHRA for weight management and subject to NICE guidance on eligibility, service setting, and treatment duration), and tirzepatide (Mounjaro check current MHRA and NICE status at the time of reading, as licensing and commissioning arrangements may have been updated) Discuss eligibility for NHS Tier 3 or Tier 4 specialist weight management services , in line with NICE guidance on obesity management, where pharmacotherapy is used as an adjunct to structured lifestyle intervention Signpost you to relevant clinical trials via the Be Part of Research portal or ClinicalTrials.gov if you wish to explore participation in retatrutide research It is important to approach information about investigational medicines with appropriate caution

Cancer Letters , 415

This one won't

UNIQUE ENERGY BOOSTER COMBINATION: Unique Combination is designed to help support gym workouts and improvise Physical performance.Cratus CoQ10 L-Carnitine L-Tartrate supports active weight loss and helps to boost energy, Its unique blend nutrients that support energy,Muscle mass and muscle recovery.CoQ10 and L-Carnitine are key nutrients to produce cellular vigour energy while maintaining nutritional support level for heart health.It also helps support CoQ10 and L-Carnitine losses due to aging